Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Am J Hematol. 2018 Sep 26;93(10):1245–1253. doi: 10.1002/ajh.25234

Figure 2. IPSS classification of test cohort and survival of external validation cohorts.

Figure 2.

A: Distribution of intermediate-favorable (int-fav) and intermediate-adverse (int-adv) test cohort groups when classified by IPSS. Survival for the two sequentially stratified prognostic groups using proposed risk score described. B: Survival based on sequential score for test cohort patients classified as IPSS intermediate-1 (int-1) risk. C: Survival based on sequential score for test cohort patients classified as IPSS intermediate-2 (int-2) risk. D: Survival of external validation cohort 1, IPSS-R int-risk patients from outside institution (n=111), classified by sequential scoring as int-favorable vs. int-adverse. E: Survival of external validation cohort 2, IPSS-R int-risk patients from outside institution (n=616), classified by sequential scoring as int-favorable vs. int-adverse.